Sonoporation-enhanced chemotherapy significantly reduces primary tumour burden in an orthotopic pancreatic cancer xenograft

Molecular Imaging and Biology

Volumn 16, Issue 1, 2014, Pages 53-62

  Kotopoulis, Spiros ^a,b   Delalande, Anthony ^c   Popa, Mihaela ^d   Mamaeva, Veronika ^b   Dimcevski, Georg ^a   Gilja, Odd Helge ^a,b   Postema, Michiel ^a,b   Gjertsen, Bjørn Tore ^b   McCormack, Emmet ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c CENTRE DE BIOPHYSIQUE MOLÉCULAIRE   (France)

^d KinN Therapeutics   (Norway)

Author keywords

3D ultrasound; Bioluminescence; Chemotherapy; Pancreatic cancer; Sonoporation; Ultrasound

Indexed keywords

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DEOXYCYTIDINE; DRUG DELIVERY SYSTEMS; HUMANS; MICE; MICE, SCID; MICROBUBBLES; PANCREATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SONICATION; SURVIVAL ANALYSIS; TRANSDUCERS; TUMOR BURDEN; ULTRASONICS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84895076137     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-013-0672-5     Document Type: Article

References (48)

1. American Cancer Society Cancer Facts and Figures (2013) http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/ document/acspc-036845.pdf
2. Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer statistics, 2000. CA Cancer J Clin 50:7-33
3. Chen EL, Prinz RA (2007) Long-term survival after pancreatic cancer treatment. Am J Surg 194:S127-S130
4. Hartlapp I, Muller J, Kenn W et al (2013) Complete pathological remission of locally advanced, unresectable pancreatic cancer (LAPC) after intensified neoadjuvant chemotherapy. Onkologie 36:123-125
5. Neoptolemos JP, Stocken DD, Friess H et al (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200-1210
6. Neoptolemos JP, Dunn JA, Stocken DD et al (2001) Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 358:1576-1585
7. el-Kamar FG, Grossbard ML, Kozuch PS (2003) Metastatic pancreatic cancer: emerging strategies in chemotherapy and palliative care. Oncologist 8:18-34
8. Marechal R, Bachet JB, Mackey JR et al (2012) Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma. Gastroenterology 143(664-674):e661-666
9. Camp-Sorell D (2010) Chemotherapy toxicities and management. In: Yarbro CH, Wujcik D, Gobel BH (eds) Cancer nursing: principles and practice. Jones & Bartlett, Sudbury
10. Erchinger FG, Dimcevski G, Engjom T, Gilja OH (2011) Transabdominal ultrasonography of the pancreas: basic and new aspects. Imaging Med 3:412-422
11. Simpson DH, Burns PN, Averkiou MA (2001) Techniques for perfusion imaging with microbubble contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control 48:1483-1494
12. Stride E, Saffari N (2003) Microbubble ultrasound contrast agents: a review. Proc Inst Mech Eng H J Eng Med 217:429-447
13. Postema MAB (2004) Medical bubbles. Michiel Postema, Bergschenhoek
14. Qiu Y, Zhang C, Tu J, Zhang D (2012) Microbubble-induced sonoporation involved in ultrasound-mediated DNA transfection in vitro at low acoustic pressures. J Biomech 45:1339-1345
15. Suzuki R, Oda Y, Utoguchi N, Maruyama K (2011) Progress in the development of ultrasound-mediated gene delivery systems utilizing nano- and microbubbles. J Control Release 149:36-41
16. Nejad SM, Hosseini SH, Akiyama H, Tachibana K (2011) Optical observations of cell sonoporation with low intensity ultrasound. Biochem Biophys Res Co 413:218-223
17. Kooiman K, Harteveld M, van der Steen AFW, de Jong N (2011) Sonoporation of endothelial cells by vibrating targeted microbubbles. J Control Release 154:35-41
18. Wu J, Pepe J, Rincon M (2006) Sonoporation, anti-cancer drug and antibody delivery using ultrasound. Ultrasonics 44:E21-E25
19. Delalande A, Kotopoulis S, Rovers T, Pichon C, Postema M (2011) Sonoporation at a low mechanical index. Bub Sci Eng Tech 3:3-11
20. van Wamel A, Bouakaz A, Bernard B, ten Cate F, de Jong N (2005) Controlled drug delivery with ultrasound and gas microbubbles. J Control Release 101:389-391
21. Emmer M, Borsboom J, Van Wamel A, Versluis M, de Jong N (2005) Optical investigation of ultrasound induced encapsulated microbubble oscillations: threshold and hysteresis effects. Proc IEEE Ultrason Symp:981-984
22. van Wamel A, Kooiman K, Harteveld M et al (2006) Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J Control Release 112:149-155
23. Postema M, Kotopoulis S, Delalande A, Gilja OH (2012) Sonoporation: why microbubbles create pores. Ultraschall in Med 33:97-98
24. Delalande A, Bouakaz A, Renault G et al (2011) Ultrasound and microbubble-assisted gene delivery in Achilles tendons: long lasting gene expression and restoration of fibromodulin KO phenotype. J Control Release 156:223-230
25. Delalande A, Kotopoulis S, Postema M, Midoux P, Pichon C (2013) Sonoporation: mechanistic insights and ongoing challenges for gene transfer. Gene 525:191-199
26. Gerold B, Rachmilevitch I, Prentice P (2013) Bifurcation of ensemble oscillations and acoustic emissions from early stage cavitation clouds in focused ultrasound. New J Phys 15:033044
27. Gerold B, Kotopoulis S, McDougall C, McGloin D, Postema M, Prentice P (2011) Laser-nucleated acoustic cavitation in focused ultrasound. Rev Sci Instrum 82:044908
28. Piscaglia F, Nolsoe C, Dietrich CF et al (2012) The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med 33:33-59
29. Ng KH (2002) International guidelines and regulations for the safe use of diagnostic ultrasound in medicine. J Med Ultrasound 10:5-9
30. British Medical Ultrasound Society (2000) Guidelines for the safe use of diagnostic ultrasound equipment. British Medical Ultrasound Society
31. Fan Z, Kumon RE, Park J, Deng CX (2010) Intracellular delivery and calcium transients generated in sonoporation facilitated by microbubbles. J Control Release 142:31-39
32. Tlaxca JL, Anderson CR, Klibanov AL et al (2010) Analysis of in vitro transfection by sonoporation using cationic and neutral microbubbles. Ultrasound Med Biol 36:1907-1918
33. Qiu Y, Luo Y, Zhang Y et al (2010) The correlation between acoustic cavitation and sonoporation involved in ultrasound-mediated DNA transfection with polyethylenimine (PEI) in vitro. J Control Release 145:40-48
34. Czarnota GJ, Karshafian R, Burns PN et al (2012) Tumor radiation response enhancement by acoustical stimulation of the vasculature. Proc Natl Acad Sci U S A 109:E2033-2041
35. Lukianova-Hleb EY, Samaniego AP, Wen J, Metelitsa LS, Chang CC, Lapotko DO (2011) Selective gene transfection of individual cells in vitro with plasmonic nanobubbles. J Control Release 152:286-293
36. Hoffman RM (1999) Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drug 17:343-359
37. Bibby MC (2004) Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages. Eur J Cancer 40:852-857
38. Greis C (2004) Technology overview: SonoVue (Bracco, Milan). Eur Radiol 14:P11-P15
39. Lu JY, Zou H, Greenleaf JF (1994) Biomedical ultrasound beam forming. Ultrasound Med Biol 20:403-428
40. Kotopoulis S, Dimcevski G, Gilja OH, Hoem D, Postema M (2013) Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: a clinical case study. Med Phys 40:072902-072909
41. Burris HA 3rd, Moore MJ, Andersen J et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403-2413
42. McCormack E, Mujic M, Osdal T, Bruserud O, Gjertsen BT (2013) Multiplexed mAbs: a new strategy in preclinical time-domain imaging of acute myeloid leukemia. Blood 121:e34-42
43. McCormack E, Silden E, West RM et al (2013) Nitroreductase, a near-infrared reporter platform for in vivo time-domain optical imaging of metastatic cancer. Cancer Res 73:1276-1286
44. Ozawa Y, Numata K, Tanaka K et al (2002) Contrast-enhanced sonography of small pancreatic mass lesions. J Ultrasound Med 21:983-991
45. Poortinga AT (2012) Micron-sized antibubbles with tunable stability. Colloids Surf A: Physiochem Eng Aspects
46. Zhang GN, Liang Y, Zhou LJ et al (2011) Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells. Cancer Lett 313:137-144
47. Michaelis M, Doerr HW, Cinatl J (2007) Valproic acid as anti-cancer drug. Curr Pharm Design 13:3378-3393
48. Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB (2007) Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res 67:3853-3861